XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 487 $ 51 $ 581 $ 51
Cost of revenues (60) 120 96 170
Gross income (loss) 547 (69) 485 (119)
Operating expenses:        
Research and development 1,001 1,387 3,446 4,560
General and administrative 3,381 4,049 11,592 10,231
Gain on lease termination (1,576) (1,576)
Acquisition of Exacis in-process research and development 460
Total operating expenses 2,806 5,436 13,462 15,251
Loss from operations (2,259) (5,505) (12,977) (15,370)
Other expense, net:        
Loss on extinguishment of debt (22,440) (22,440)
Fair value adjustments to bridge notes derivative liability (1,038) (1,038)
Change in fair value of warrant liabilities 831 20 897 166
Change in fair value of contingent consideration 66 118
Loss on non-controlling investment (59)
Interest expense, net (1,686) (113) (3,269) (88)
Other expense, net (1) (281)
Total other expense, net (24,333) (94) (25,784) (144)
Loss before income taxes (26,592) (5,599) (38,761) (15,514)
(Provision) benefit for income taxes (12) 8 (19) (1)
Net loss (26,604) (5,591) (38,780) (15,515)
Series A preferred stock dividend (8) (8)
Net loss attributable to common stockholders $ (26,604) $ (5,591) $ (38,788) $ (15,523)
Net loss per common share - basic $ (4.92) $ (1.03) $ (7.17) $ (2.94)
Net loss per common share - diluted $ (4.92) $ (1.03) $ (7.17) $ (2.94)
Weighted average shares outstanding - basic 5,410 5,410 5,410 5,281
Weighted average shares outstanding - diluted 5,410 5,410 5,410 5,281